SCHEMBL23748636

SCHEMBL23748636

CCCCCOc1cccc(OC)c1C(=O)O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.66
CA1 P00915 1/20 0.66
CA2 P00918 1/20 0.66
CA7 P43166 1/20 0.66
CA9 Q16790 1/20 0.66
CA14 Q9ULX7 1/20 0.66
PPARA Q07869 1/20 0.65
PLK1 P53350 1/20 0.51
TP53 P04637 1/20 0.50
TSHR P16473 1/20 0.50
PTPN1 P18031 1/20 0.50
MEN1 O00255 1/20 0.50
NR1I2 O75469 1/20 0.50
LMNA P02545 1/20 0.50
CHRM2 P08172 1/20 0.50
CYP3A4 P08684 1/20 0.50
ADRA2A P08913 1/20 0.50
MAPT P10636 1/20 0.50
OPRK1 P41145 1/20 0.50
HTR2B P41595 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13607858 0.90 CA12 (0.70) CA12CA1CA2CA7CA9
SCHEMBL28423316 0.89 CA12 (0.55) CA12CA1CA2CA7CA9
SCHEMBL23748725 0.86 PPARA (0.52) CA12CA1CA2CA7CA9
SCHEMBL29205224 0.85 PPARA (0.56) PPARAPLK1MEN1NR1I2LMNA
SCHEMBL23748674 0.84 PPARA (0.50) PPARATP53TSHRPTPN1MEN1
SCHEMBL8085939 0.84 MEN1 (0.57) PPARAPTPN1MEN1NR1I2LMNA
SCHEMBL14953710 0.83 CA12 (0.75) CA12CA1CA2CA7CA9
SCHEMBL9712657 0.83 KMT2A (0.57) CA12CA1CA2CA7CA9
SCHEMBL9153749 0.83 LMNA (0.60) PPARATSHRPTPN1MEN1NR1I2
SCHEMBL9504277 0.83 MEN1 (0.52) PPARATP53TSHRPTPN1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12473249-B2 Aromatic compounds and pharmaceutical uses thereof BASF AS (NO) 2025-11-18 US disclosed
US-20210380521-A1 AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF BASF AS (NO) 2021-12-09 US disclosed
US-20210380521-A1 AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF BASF AS (NO) 2021-12-09 US disclosed
EP-3864001-A1 ROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF BASF AS (NO) 2021-08-18 EP disclosed
CN-113166024-A Aromatic compounds and their medical use 巴斯夫股份公司 2021-07-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12473249-B2 Aromatic compounds and pharmaceutical uses thereof GLS2, FFAR3, SLC10A1 CA12 1054/4885CA1 1272/4885CA2 794/4885
US-20210380521-A1 AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF GLS2, FFAR3, SLC10A1 CA12 1054/4885CA1 1272/4885CA2 794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.